Gilead Sciences (GILD) Net Income - Minority (2011 - 2021)

Gilead Sciences (GILD) posted Net Income - Minority of -$7.0 million for Q2 2021, up 41.67% quarter-over-quarter from -$12.0 million in Q1 2021, and up 93.91% year-on-year from -$3.6 million in Q2 2020.

Gilead Sciences (GILD) Net Income - Minority (2011 - 2021) Analysis & Trends

Gilead Sciences (GILD) has reported Net Income - Minority for 11 consecutive years, with -$7.0 million the latest figure, recorded in Q2 2021.

  • Net Income - Minority for Q2 2021 came in at -$7.0 million, up 93.91% year-over-year; the trailing twelve-month figure through Jun 2021 was -$7.0 million (up 93.91% YoY), and the FY2020 annual result was -$19.0 million, up 84.8% from the prior year.
  • Net Income - Minority was -$7.0 million for Q2 2021 at Gilead Sciences, up from -$12.0 million in the prior quarter.
  • Over five years, Net Income - Minority peaked at -$7.0 million in Q2 2021 and troughed at -$476.0 million in Q1 2017.
  • Average Net Income - Minority over 5 years is -$144.2 million, with a median of -$120.0 million recorded in 2019.
  • Year-over-year, Net Income - Minority plunged 149.15% in 2018 and jumped 93.91% in 2021.
  • Over 5 years, Net Income - Minority stood at -$59.0 million in 2017, then slumped by 149.15% to -$147.0 million in 2018, then grew by 14.97% to -$125.0 million in 2019, then soared by 84.8% to -$19.0 million in 2020, then soared by 63.16% to -$7.0 million in 2021.
  • Per Business Quant data, the three most recent Net Income - Minority figures were -$7.0 million in Q2 2021, -$12.0 million in Q1 2021, and -$19.0 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2021 -7.00 Mn
Mar 31, 2021 -12.00 Mn
Dec 31, 2020 -19.00 Mn
Sep 30, 2020 -26.00 Mn
Jun 30, 2020 -115.00 Mn
Mar 31, 2020 -112.00 Mn
Dec 31, 2019 -125.00 Mn
Sep 30, 2019 -132.00 Mn
Jun 30, 2019 -135.00 Mn
Mar 31, 2019 -140.00 Mn
Dec 31, 2018 -147.00 Mn
Sep 30, 2018 -146.00 Mn
Jun 30, 2018 -62.00 Mn
Mar 31, 2018 -60.00 Mn
Dec 31, 2017 -59.00 Mn
Sep 30, 2017 -409.00 Mn
Jun 30, 2017 -414.00 Mn
Mar 31, 2017 -476.00 Mn
Dec 31, 2016 -476.00 Mn
Sep 30, 2016 -492.00 Mn